Skip to main content

Advertisement

SpringerLink
Log in

Recombinant Interleukin-1α, Interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Recombinant Interleukin-1α (IL-1α), Interleukin-2 (IL-2) and recombinant macrophage colony-stimulating factor-1 (M-CSF-1) as well as combinations of IL-2 and M-CSF-1 were studied for their ability to protect seven-day-old C57BL/6 mice against HSV-1 infection. Treatment of the mice with IL-2, M-CSF-1 or combinations of IL-2 and M-CSF-1 significantly increased survival rates. Treatment with IL-1α (10 U and 100 U/mouse) was most effective in protection against HSV-1, resulting in significantly increased survival rates more than four times greater than the survival rate of the infected control group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baron S, Worthington MG, Williams J, Gaines JW (1976) Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature 261: 505–506

    Google Scholar 

  2. Ben-Hur T, Rösen-Wolff A, Lamadé W, Darai G, Becker Y (1988) HSV-1 DNA sequence determining intraperitoneal pathogenicity in mice is required for transcription of viral immediate-early genes in macrophages. Virology 163: 397–404

    Google Scholar 

  3. Cho CT, Feng KK, Brahmacupta N (1976) Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to IHerpesvirus hominis. J Infect Dis 133: 157–167

    Google Scholar 

  4. De Luca D, Mizel SB (1986) Ia-positive nonlymphoid cells and T-cell development in murine fetal thymus organ cultures: interleukin-1 circumvents the block in T-cell differentation induced by monoclonal anti-Ia antibodies. J Immunol 137: 1435–1441

    Google Scholar 

  5. Dinarello CA (1984) Interleukin-1. Rev Infect Dis 6: 51–95

    Google Scholar 

  6. Dinarello CA (1988) Biology of interleukin-1. FASEB J 2: 108–115

    Google Scholar 

  7. Dinarello CA, Clark BD, Puren AJ, Savage N, Rosoff PM (1989) The interleukin-1 receptor. Immunol Today 10: 49–51

    Google Scholar 

  8. Georgiades JA, Montgomery J, Hughes TK, Jensen D, Baron S (1982) Determinants of protection by human immune globulin against experimental herpes neonatorum (41433). Proc Soc Exp Biol Med 170: 291–297

    Google Scholar 

  9. Gray PW, Glaiser D, Chen E, Goeddel DV, Pennica D (1986) Two interleukin-1 genes in the mouse: cloning and expression of the cDNA for the murine interleukin-1β. J Immunol 137: 3644–3648

    Google Scholar 

  10. Halenbeck R, Kawasaki E, Wrin J, Koths R (1989) Renaturation and purification of biological active recombinant human macrophage colony-stimulating factor expressed inE. coli. Bio/Technology 7: 710–715

    Google Scholar 

  11. Herrmann F, Cannistra SA, Levine H, Griffin JD (1985) Expression of interleukin-2 receptors and binding of interleukin-2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med 62: 1111–1116

    Google Scholar 

  12. Holter W, Goldman CK, Casabo L, Nelson DL, Greene WC, Waldmann TA (1987) Expression of functional IL-2 receptors by lipopolysaccharide and interferon-γ stimulated human monocytes. J Immunol 138: 2917–2922

    Google Scholar 

  13. Kohl S (1989) The neonatal human's immune response to herpes simplex virus infection: a critical review. Pediatr Infect Dis 8: 67–74

    Google Scholar 

  14. Kohl S, Cox PA, Loo LS (1987) Defective production of antibody to herpes simplex virus in neonates: defective production of T helper lymphokine and induction of suppression. J Infect Dis 155: 1179–1187

    Google Scholar 

  15. Kohl S, Loo LS (1980) Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells. Infect Immun 30: 847–850

    Google Scholar 

  16. Kohl S, Loo LS (1988) Use of interleukin-2 and macrophages to treat herpes simplex virus infection in neonatal mice. J Infect Dis 157: 1187–1192

    Google Scholar 

  17. Kohl S, Loo LS, Drath DB, Cox P (1989) Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, γ-interferon-induced mechanism. J Infect Dis 159: 239–247

    Google Scholar 

  18. Kohl S, Loo LS, Gonik B (1984) Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells. J Infect Dis 150: 14–19

    Google Scholar 

  19. Kohl S, Thomas JW, Loo LS (1986) Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophage and T helper lymphocytes from nonimmune adult syngeneic mice. J Immunol 136: 3038–3044

    Google Scholar 

  20. Kohl S, West MS, Loo LS (1988) Defects in interleukin-2 stimulation of neonatal natural killer cytotoxicity to herpes simplex virus-infected cells. J Pediatr 112: 976–981

    Google Scholar 

  21. Koide S, Steinman RM (1988) Induction of interleukin-1 mRNA during antigen-dependent interaction of sensitized T lymphoblasts with macrophages. J Exp Med 168: 409–416

    Google Scholar 

  22. Koyama H, Kasahara S (1975) Induction of herpes simplex virus immunity in newborn mice. Infect Immun 12: 1472–1474

    Google Scholar 

  23. Ladner MB, Martin GA, Noble JA, Nikoloff DM, Tal R, Kawasaki ES, White TJ (1987) Human CSF-1: gene structure and alternative splicing of mRNA precursors. EMBO J 6: 2693–2698

    Google Scholar 

  24. Lomedico PT, Gubler U, Hellman CP, Dukowich M, Giri JG, Pan YE, Collier K, Semiononov R, Chua AO, Mizel SB (1984) Cloning and expression of murine interleukin-1 cDNA inE. coli. Nature 312: 458–462

    Google Scholar 

  25. Lotze MT, Chang AE, Seipp CA, Simpson C, Vetto JT, Rosenberg SA (1986) High-dose recombinant interleukin-2 in the treatment of patients with disseminated cancer. JAMA 256: 3117–3124

    Google Scholar 

  26. Luyet F, Samra D, Soneji A, Marks MI (1975) Passive immunization in experimentalHerpesvirus hominis infection of newborn mice. Infect Immun 12: 1258–1261

    Google Scholar 

  27. Peles E, Rosen H, Darai G, Rösen-Wolff A, Becker Y (1990) Importance of the Hpa I-P sequence for herpes simplex virus-1 replication in the adrenal glands. Arch Virol 113: 151–163

    Google Scholar 

  28. Rosenberg SA, Grimm EA, McGrogan M, Doyle M, Kawasaki E, Koths K, Mark DF (1984) Biological activity of recombinant human interleukin-2 produced inE. coli. Science 223: 1412–1415

    Google Scholar 

  29. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Reichert CM (1985) Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485–1492

    Google Scholar 

  30. Rosenstein M, Ettinghausen SE, Rosenberg SA (1986) Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. J Immunol 127: 1735–1742

    Google Scholar 

  31. Sarmiento M (1988) Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication. J Immunol 141: 2740–2748

    Google Scholar 

  32. Shellam GR, Flexman JP (1986) Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice. J Virol 58: 152–156

    Google Scholar 

  33. Sprecher E, Becker Y (1990) Induction of interleukin-1α and β gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1. Arch Virol 110: 259–269

    Google Scholar 

  34. Strulovitch C, Marks MI, Soneji A, Goldberg S (1979) Immunotherapy and drugs in neonatal disseminated herpes simplex virus type 2 infections: a mouse model. J Antimicrob Chemother 5: 437–446

    Google Scholar 

  35. Tenney DJ, Morahan PS (1987) Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex virus type 1. J Immunol 139: 3076–3083

    Google Scholar 

  36. Ulich TR, del Castillo J, Guo K, Souza L (1989) The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1 and granulocyte-stimulating colony factor on bone marrow circulation. Am J Pathol 143: 149–159

    Google Scholar 

  37. Van der Meer JWM, Barza M, Wolff SM, Dinarello CA (1988) A low dose of recombinant interleukin-1 protects granulocytopenic mice from a lethal Gram-negative infection. Proc Natl Acad Sci USA 85: 1620–1623

    Google Scholar 

  38. Wang A, Lu SD, Mark DF (1984) Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 224: 1431–1433

    Google Scholar 

  39. Warren MK, Ralph P (1986) Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 137: 2281–2285

    Google Scholar 

  40. Weinberg A, Konrad M, Merrigam TC (1987) Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs. J Virol 61: 2120–2127

    Google Scholar 

  41. Zawatzky R, Engler H, Kirchner H (1982) Experimental infection of inbred mice with herpes simplex virus. III. Comparisons between newborn and adult C57BL/6 mice. J Gen Virol 60: 25–29

    Google Scholar 

  42. Zisman B, Hirsh MS, Allison AC (1970) Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes simplex virus infection of young adult mice. J Immunol 104: 1155–1159

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Virology, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

    C. Berkowitz & Y. Becker

Authors
  1. C. Berkowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berkowitz, C., Becker, Y. Recombinant Interleukin-1α, Interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1. Archives of Virology 124, 83–93 (1992). https://doi.org/10.1007/BF01314627

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01314627

Keywords

Search

Navigation